EP1576010A4 - Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix - Google Patents
Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ixInfo
- Publication number
- EP1576010A4 EP1576010A4 EP03749129A EP03749129A EP1576010A4 EP 1576010 A4 EP1576010 A4 EP 1576010A4 EP 03749129 A EP03749129 A EP 03749129A EP 03749129 A EP03749129 A EP 03749129A EP 1576010 A4 EP1576010 A4 EP 1576010A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- tumor
- therapy
- expression
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40557702P | 2002-08-23 | 2002-08-23 | |
US405577P | 2002-08-23 | ||
US64693403A | 2003-08-22 | 2003-08-22 | |
US646934 | 2003-08-22 | ||
PCT/US2003/026612 WO2004017923A2 (en) | 2002-08-23 | 2003-08-25 | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1576010A2 EP1576010A2 (en) | 2005-09-21 |
EP1576010A4 true EP1576010A4 (en) | 2006-12-27 |
Family
ID=31949897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03749129A Withdrawn EP1576010A4 (en) | 2002-08-23 | 2003-08-25 | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1576010A4 (en) |
JP (1) | JP2005536220A (en) |
AU (1) | AU2003268180A1 (en) |
CA (1) | CA2496572A1 (en) |
WO (1) | WO2004017923A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1487972B1 (en) | 2002-02-21 | 2015-08-12 | Institute Of Virology | Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use |
US7833734B2 (en) | 2002-11-26 | 2010-11-16 | Institute Of Virology Of The Slovak Academy Of Sciences | CA IX-specific inhibitors |
DOP2006000277A (en) | 2005-12-12 | 2007-08-31 | Bayer Pharmaceuticals Corp | ANTI MN ANTIBODIES AND METHODS FOR USE |
WO2008091798A2 (en) * | 2007-01-22 | 2008-07-31 | Xencor, Inc. | Optimized ca9 antibodies and methods of using the same |
EP2234608A2 (en) * | 2007-12-11 | 2010-10-06 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
EP3966253A4 (en) * | 2019-05-06 | 2023-02-22 | Navi Bio-Therapeutics, Inc. | Anti-carbonic anhydrase ix antibody |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000024913A2 (en) * | 1998-10-23 | 2000-05-04 | Bayer Corporation | Mn gene and protein |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5955075A (en) * | 1992-03-11 | 1999-09-21 | Institute Of Virology, Slovak Academy Of Sciences | Method of inhibiting tumor growth using antibodies to MN protein |
-
2003
- 2003-08-25 CA CA002496572A patent/CA2496572A1/en not_active Abandoned
- 2003-08-25 EP EP03749129A patent/EP1576010A4/en not_active Withdrawn
- 2003-08-25 AU AU2003268180A patent/AU2003268180A1/en not_active Abandoned
- 2003-08-25 JP JP2004531195A patent/JP2005536220A/en not_active Withdrawn
- 2003-08-25 WO PCT/US2003/026612 patent/WO2004017923A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000024913A2 (en) * | 1998-10-23 | 2000-05-04 | Bayer Corporation | Mn gene and protein |
Non-Patent Citations (1)
Title |
---|
J. SAARNIO ET EL.: "Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.", AMERICAN JOURNAL OF PATHOLOGY, vol. 153, no. 1, 1998, pages 279 - 285 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004017923A2 (en) | 2004-03-04 |
JP2005536220A (en) | 2005-12-02 |
EP1576010A2 (en) | 2005-09-21 |
AU2003268180A8 (en) | 2004-03-11 |
WO2004017923A3 (en) | 2005-07-14 |
CA2496572A1 (en) | 2004-03-04 |
AU2003268180A1 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003302892A8 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
EP1515982A4 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
EP1571968A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1589933A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003293194A8 (en) | Compositions and methods for treating prostate cancer | |
AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
EP1571968A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1572091A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1553912A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1578996A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1572091A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003224076A1 (en) | Antibody combination useful for tumor therapy | |
EP1575571A4 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1551388A4 (en) | Compounds useful for the treatment of cancer, compositions thereof and methods therewith | |
EP1349485A4 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
AU3483001A (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2003268180A8 (en) | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix | |
AU2003219160A1 (en) | Methods and compositions for the treatment of cancer | |
AU2003230849A8 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
EP1587405A4 (en) | Novel compositions and methods for cancer | |
AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
EP1684795A4 (en) | Methods and agents for the treatment of cancer | |
AU2003293665A8 (en) | Compositions and methods for treating cancer using cytotoxic cd44 antibody immunoconjugates and radiotherapy | |
AU2002332606A8 (en) | Compositions and methods for the therapy and diagnosis of colon cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050315 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20061128 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
|
17Q | First examination report despatched |
Effective date: 20090602 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20091123 |